Back to Report

Epigenetics Therapeutics to 2017 – High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma

  • Published: Jul-2010
  • Report Code: GBIHC039MR
  • Report Format: pdf
Email to a colleague
Enquiry Before Buying
      captcha refresh
     

I have read and accept terms and conditions and privacy policy

Cancel
 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
 
      captcha refresh
     

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards